Nanogen Announces Intent to Restructure
Nanogen Inc announced that it is evaluating strategic alternatives for its microarray business as part of an aggressive plan to achieve profitability.
Read MoreNanogen Inc announced that it is evaluating strategic alternatives for its microarray business as part of an aggressive plan to achieve profitability.
Read MoreSymposium on Sept 26 focuses on strategies for protein biomarker discovery, validation, and characterization.
Read MoreAACC is advocating for the repeal of CMSs demonstration project to competitively bid clinical lab services.
Read MoreThe Center for Genetics and Society calls for a moratorium on enrolling some patients in experimental gene therapy procedures.
Read MoreThe American College of Emergency Physicians (ACEP) plans to host its annual Scientific Assembly in Seattle next month.
Read More